283 related articles for article (PubMed ID: 25896000)
1. Methods and assays for specific targeting and delivery of RNA nanoparticles to cancer metastases.
Rychahou P; Shu Y; Haque F; Hu J; Guo P; Evers BM
Methods Mol Biol; 2015; 1297():121-35. PubMed ID: 25896000
[TBL] [Abstract][Full Text] [Related]
2. Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumor.
Lee TJ; Haque F; Vieweger M; Yoo JY; Kaur B; Guo P; Croce CM
Methods Mol Biol; 2015; 1297():137-52. PubMed ID: 25896001
[TBL] [Abstract][Full Text] [Related]
3. Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration.
Rychahou P; Haque F; Shu Y; Zaytseva Y; Weiss HL; Lee EY; Mustain W; Valentino J; Guo P; Evers BM
ACS Nano; 2015 Feb; 9(2):1108-16. PubMed ID: 25652125
[TBL] [Abstract][Full Text] [Related]
4. Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.
Shu Y; Haque F; Shu D; Li W; Zhu Z; Kotb M; Lyubchenko Y; Guo P
RNA; 2013 Jun; 19(6):767-77. PubMed ID: 23604636
[TBL] [Abstract][Full Text] [Related]
5. Overview of methods in RNA nanotechnology: synthesis, purification, and characterization of RNA nanoparticles.
Haque F; Guo P
Methods Mol Biol; 2015; 1297():1-19. PubMed ID: 25895992
[TBL] [Abstract][Full Text] [Related]
6. Targeting the extracellular signature of metastatic colorectal cancers.
Marchiò S; Arap W; Pasqualini R
Expert Opin Ther Targets; 2009 Mar; 13(3):363-79. PubMed ID: 19236157
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
Pridgen EM; Langer R; Farokhzad OC
Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
[TBL] [Abstract][Full Text] [Related]
8. Unique benefits of nanotechnology to drug delivery and diagnostics.
McNeil SE
Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
[TBL] [Abstract][Full Text] [Related]
10. Cellular Delivery of RNA Nanoparticles.
Parlea L; Puri A; Kasprzak W; Bindewald E; Zakrevsky P; Satterwhite E; Joseph K; Afonin KA; Shapiro BA
ACS Comb Sci; 2016 Sep; 18(9):527-47. PubMed ID: 27509068
[TBL] [Abstract][Full Text] [Related]
11. Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics.
Dahlman JE; Kauffman KJ; Xing Y; Shaw TE; Mir FF; Dlott CC; Langer R; Anderson DG; Wang ET
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2060-2065. PubMed ID: 28167778
[TBL] [Abstract][Full Text] [Related]
12. Targeted nanoparticles for colorectal cancer.
Cisterna BA; Kamaly N; Choi WI; Tavakkoli A; Farokhzad OC; Vilos C
Nanomedicine (Lond); 2016 Sep; 11(18):2443-56. PubMed ID: 27529192
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology for delivery of peptide nucleic acids (PNAs).
Gupta A; Bahal R; Gupta M; Glazer PM; Saltzman WM
J Control Release; 2016 Oct; 240():302-311. PubMed ID: 26776051
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine approaches in acute lymphoblastic leukemia.
Tatar AS; Nagy-Simon T; Tomuleasa C; Boca S; Astilean S
J Control Release; 2016 Sep; 238():123-138. PubMed ID: 27460684
[TBL] [Abstract][Full Text] [Related]
15. Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology.
Binzel DW; Shu Y; Li H; Sun M; Zhang Q; Shu D; Guo B; Guo P
Mol Ther; 2016 Aug; 24(7):1267-77. PubMed ID: 27125502
[TBL] [Abstract][Full Text] [Related]
16. Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer.
Fortina P; Kricka LJ; Graves DJ; Park J; Hyslop T; Tam F; Halas N; Surrey S; Waldman SA
Trends Biotechnol; 2007 Apr; 25(4):145-52. PubMed ID: 17316852
[TBL] [Abstract][Full Text] [Related]
17. Nano-Drug Delivery Systems Based on Different Targeting Mechanisms in the Targeted Therapy of Colorectal Cancer.
Wang K; Shen R; Meng T; Hu F; Yuan H
Molecules; 2022 May; 27(9):. PubMed ID: 35566331
[TBL] [Abstract][Full Text] [Related]
18. Application of nanotechnology in biomedicine.
Navalakhe RM; Nandedkar TD
Indian J Exp Biol; 2007 Feb; 45(2):160-5. PubMed ID: 17375555
[TBL] [Abstract][Full Text] [Related]
19. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
Nguyen KT; Zhao Y
Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
[TBL] [Abstract][Full Text] [Related]
20. Targeting of nanoparticles in cancer: drug delivery and diagnostics.
Talekar M; Kendall J; Denny W; Garg S
Anticancer Drugs; 2011 Nov; 22(10):949-62. PubMed ID: 21970851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
